Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.8 USD | +4.27% | +1.66% | -3.67% |
04:39pm | Johnson & Johnson Seeks EU Approval for Ulcerative Colitis, Crohn’s Disease Drug | MT |
04:17pm | Johnson & Johnson Announces $6.48 Billion Plan for Unit to Resolve Ovarian Cancer Talc Claims | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.67% | 348B | |
+32.89% | 704B | |
+28.59% | 577B | |
+18.41% | 327B | |
+5.15% | 288B | |
+14.83% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.14% | 147B | |
-7.90% | 145B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- HSBC Upgrades Johnson & Johnson to Buy From Hold, Raises Price Target to $170 From $169